The 22nd Annual Duke Debates: Controversies in the Management of Patients with Hematologic Malignancies

April 30, 2021 to May 2, 2021

This annual event brings together experts in the field of Hematologic Malignancies to debate and discuss advances in the treatment for these cancers, novel treatment options, and debate current treatment paradigms. There is a mini session focusing on the management of immunotherapy and its use in solid tumors. 

Learning Objectives

  • Describe emerging data and recent advances in the management of both malignant and benign hematologic disease. 
  • Examine the use of immunotherapy in the management of solid tumors. 
  • Compare traditional and emerging treatment options in the management of hematologic disease.
  • Examine the decision making strategies considered in the management of multiple myeloma including choosing the optimal induction regimen, the role of immunotherapy and the management of refractory disease. 
  • Discuss the role and economics of CAR-T in the cancer population.
     
Course summary
Available credit: 
  • 12.00 ABIM MOC
  • 12.00 ACPE - Pharmacist
  • 12.00 ACPE - Pharmacy Technician
  • 12.00 AMA PRA Category 1 Credit(s)
  • 12.00 ANCC
  • 12.00 Attendance
  • 12.00 JA Credit - AH
Registration Opens: 
05/02/2021
Registration Expires: 
05/01/2022
Activity Starts: 
04/30/2021 - 7:00am
Activity Ends: 
05/02/2021 - 12:30pm
Rating: 
0
Durham, NC 27710
United States

Available Credit

  • 12.00 ABIM MOC
  • 12.00 ACPE - Pharmacist
  • 12.00 ACPE - Pharmacy Technician
  • 12.00 AMA PRA Category 1 Credit(s)
  • 12.00 ANCC
  • 12.00 Attendance
  • 12.00 JA Credit - AH
Please login or register to take this course.